-
Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants
Montero-Lopez, R., Farman, M. R., Högler, F., Rehder, C., Malli, T., Webersinke, G., Rockman-Greenberg, C., Dahir, K., Martos-Moreno, G. Á., Linglart, A., Ozono, K., Seefried, L., Del Angel, G., Nading, E. B., Huggins, E., Rush, E. T., Tauer, J. T., Kishnani, P. S. & Högler, W., 01 Mar 2026, In: Journal of Bone and Mineral Research. 41, 3, p. 259-269 11 p., zjaf124.Research output: Contribution to journal › Article › peer-review
Open Access -
The endoplasmic reticulum proteostasis network and bone disease
Farhan, H., Zahoor, M., Tauer, J. T. & Högler, W., Feb 2026, In: Trends in Molecular Medicine. 32, 2, p. 119-132 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
A 17-Year-Old Female with Recurrent Atraumatic Hemarthrosis
Weinberger, M.-L., Zeilinger, S., Högler, W. & Scala, M., 20 Aug 2025, In: Monatsschrift Kinderheilkunde. S 2, p. 125 P04-04.Research output: Contribution to journal › Poster Abstract › peer-review
-
ABCD-Syndrom als Ursache einer persistierenden Hyperkalzämie bei Trisomie 21
Schirl, J., Laurer, E., Hörtenhuber, T., Blaschitz, A., Fritz, T., Tamas, M., Högler, W. & Montero-Lopez, R., 20 Aug 2025, In: Monatsschrift Kinderheilkunde. S 2, p. 117 P02-04.Research output: Contribution to journal › Poster Abstract › peer-review
-
CED-ähnliche Symptomatik bei einem Jungen mit Adenosindesaminase-2-Mangel (DADA-2)
Rack, K., Minichmayr, E., Lanzersdorfer, R. & Högler, W., 20 Aug 2025, In: Monatsschrift Kinderheilkunde. S 2, p. 120 P03-05.Research output: Contribution to journal › Poster Abstract › peer-review
-
CARE4RARE: Education & Care in RARE - Wirksamkeit einer gezielten psychoedukativen Intervention zur Verbesserung des Wissens über Seltene Krankheiten und zur Förderung der psychischen Gesundheit von Patienten mit seltenen pädiatrischen Krankheiten: Studienprotokoll für eine randomisierte kontrollierte Studie mit Warteliste
Högler, W. (Researcher), Tamas, M. (Researcher) & Ludwiczek, J. (Researcher)
17.10.2025 → 16.10.2027
Project: Clinical studies › Clinical Study (Academic - no third-party funds)
-
GHD: The Growth Hormone Deficiency Reversal Study: Effect on final height of discontinuation vs continuation of growth hormone treatment in pubertal children with isolated growth hormone deficiency – An observational prospective non-inferiority study
Högler, W. (Researcher)
15.10.2025 → 14.10.2033
Project: Other › Project from scientific scope of research unit
-
The ALPL Gene Variant Database: A ClinGen VCEP
Högler, W. (Researcher) & Farman, M. (Researcher)
09.10.2025 → 08.10.2029
Project: Clinical studies › Clinical Study (Other)
-
reACHin: A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-controlled Trial, evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly for 52 Weeks in Infants (0 to <2 years of age) with Achondroplasia followed by an Open Label Extension (OLE) period
Montero Lopez, R. (Researcher) & Högler, W. (PI)
30.06.2024 → 31.12.2030
Project: Clinical studies › Clinical Study (Industry project)
-
AttaCH: A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children and Adolescents with Achondroplasia
Hörtenhuber, T. (Researcher), Montero Lopez, R. (Researcher), Tischlinger, K. (Researcher) & Högler, W. (PI)
06.12.2023 → 31.12.2030
Project: Clinical studies › Clinical Study (Industry project)
Activities
-
Genetics of Short Stature: Syndromes and Bone Disorders
Högler, W. (Speaker)
21 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science
-
HPP-from bench to bedside
Högler, W. (Speaker)
20 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science
-
„Kleinwuchs – Next Generation“
Högler, W. (Speaker)
15 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science
-
-
Vitamin D – Wann messen? Wen supplementieren?
Högler, W. (Speaker)
16 Oct 2025Activity: Talk or presentation › Invited talk › science-to-science